12 weeks of lifting strengthened breathing muscles and raised an anti-aging protein in adults 60 to 75

Edited by Samael A. Tejada, Founder & Editor-in-Chief

The most useful longevity interventions are rarely exotic. This trial adds a specific, measurable benefit to a familiar one — stronger breathing muscles after 60 — and pairs it with blood-marker changes (less IL-6, more IL-10, more Klotho) that aging researchers watch closely. What it does not do is measure mitochondria directly, and readers deserve that distinction up front.

What exactly improved after 12 weeks?

Sixty older adults were randomized to a supervised 12-week resistance-training program or a control group. The training group improved on every functional measure the team reported: maximal inspiratory pressure and maximal expiratory pressure (the standard gauges of respiratory muscle strength), handgrip strength, and the one-minute sit-to-stand test, while attenuating the fall in oxygen saturation during exercise. Anthropometric changes were modest and systemic blood counts did not change significantly — the gains were functional and inflammatory, not cosmetic.

What is Klotho, and why do aging researchers care?

Klotho is a protein first identified as an aging regulator: animals lacking it age prematurely, and higher circulating levels in humans are associated with healthier aging. In this trial, circulating Klotho increased markedly in the training group alongside a favorable inflammatory shift — plasma IL-6 fell and IL-10 rose. The authors read that combination as an anti-inflammatory, anti-aging response to training. It is a biomarker result, not proof that training extended anyone's lifespan, and the trial was not designed to show that.

Where do mitochondria honestly fit?

Breathing muscles such as the diaphragm, and the limb muscles trained in this program, depend on dense mitochondrial networks to sustain repeated contractions, and mitochondrial decline in muscle is a documented part of aging and sarcopenia. But this study took no muscle biopsies and ran no respiration assays: any claim that 12 weeks of lifting rebuilt mitochondria in these participants would go beyond its data. The honest summary is narrower and still worthwhile — supervised resistance training improved respiratory muscle strength and systemic inflammatory markers in older adults, outcomes that sit downstream of the muscle energetics mitochondria support.

Where the evidence stands

• Established: Aging brings sarcopenia, chronic low-grade inflammation and reduced respiratory muscle strength; resistance training is an established countermeasure for muscle strength and functional capacity in older adults.
• Preliminary: In a randomized trial of 60 adults aged 60-75 (Journal of Functional Morphology and Kinesiology, 2026), 12 weeks of supervised resistance training improved inspiratory and expiratory muscle pressures, grip strength and sit-to-stand performance, reduced IL-6, and increased IL-10 and circulating Klotho versus controls.
• Absent: Direct mitochondrial measurements in this trial (no biopsies or respiration assays), and any evidence on lifespan, disease incidence or long-term durability of the Klotho change.